Business Wire - June 08, 2009
...s' Development
of Zaleplon-Based Sleep-Maintenance Treatment
demonstrates that new controlled-release formulations of a marketed insomnia medication have shown a pharmacodynamic profile ......lations
Relationship of Subjective and Objective Endpoints for Outcomes of a Phase I Trial of a Potential New Sleep Agent
About MOTN Awakening
A frequent and significant complaint of insomnia patients is middle-of-the-night (MOTN) awakening....
See more references to Insomnia in this document
The Advocate. The National Gay & Lesbian Newsmagazine - Nbr. 2005, January 2005
The National Sleep Foundation's annual sleep poll finds that as many as 50% of all Americans experience insomnia a few times a week. The organization stresses ...
See more references to Insomnia in this document
Saturday Evening Post - Vol. 278 Nbr. 3, May 2006
No wonder I'm an insomniac. How can I get to sleep when I keep trying to ...
See more references to Insomnia in this document
San Diego Business Journal - April 05, 2004
...
Neurocrine's indiplon, which is anticipated to go up for Food and Drug Administration approval in mid-year, showed positive results in late-stage insomnia trials by helping patients to fall asleep faster ...
See more references to Insomnia in this document
New Hampshire Business Review - June 20, 2008
... Researchers at the University of California-San Diego studied 2,226 women aged 60 and older and found that less daytime napping and fewer complaints of insomnia best predicted successful aging. On the flip ...
See more references to Insomnia in this document
USA Today Magazine - Vol. 129 Nbr. 2669, February 2001
If you are counting sheep all night, you're not alone, because insomnia affects one in three Americans. However, it is ...... "Insomnia is a prevalent and serious condition that is ......"
Although insomnia often is regarded as just a nuisance, it can ...
See more references to Insomnia in this document
Business Wire - July 13, 2008
BRANFORD, Conn. -- Neurogen Corporation (Nasdaq: NRGN) today announced that, as planned, it commenced a Phase 2/3 clinical trial in chronic insomnia patients with the Company's insomnia agent, ......
About Neurogen's Insomnia Program
Adipiplon has been tested in Phase 1 ...
See more references to Insomnia in this document
San Diego Business Journal - July 21, 1997
Insomnia is emerging as a serious health issue. ......
Emerging Therapies for Insomnia and Other Circadian Rhythm Disorders, a DR ......
* 40 percent of insomniacs and 46.5 percent of hypersomniacs suffer from a ...
See more references to Insomnia in this document
USA Today Magazine - Vol. 122 Nbr. 2581, October 1993
Chronic and intermittent sleep disorders affect almost 70 million Americans and cause an economic loss of $16 billion each year. Even occasional insomnia impairs concentration and memory. The smallest effective dose of benzodiazepine is the recommended therapy.
See more references to Insomnia in this document
